Skip to content

Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer

Pilot Study of the Hand-held In Vivo Confocal Microscopy Probe for Detection of Cervical Intraepithelial Neoplasia

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02574442
Acronym
Confocal
Enrollment
60
Registered
2015-10-12
Start date
2019-09-01
Completion date
2020-06-01
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Precancerous Condition

Keywords

cervical intraepithelial neoplasia grade 1, cervical intraepithelial neoplasia grade 2, cervical intraepithelial neoplasia grade 3, adenocarcinoma in situ

Brief summary

The goal of this proposal is to determine whether a hand-held confocal microscopy probe may perform better than standard methods in detecting cancer or pre-cancerous abnormalities of the cervix. The confocal probe will provide invivo histopathology-like images of cell morphology and three-dimensional tissue architecture non-invasively in real time.

Detailed description

All subjects will undergo standard management (colposcopy) for their cervical lesion as scheduled. For cervical sites suspicious of dysplasia, acriflavine hydrochloride 0.05% solution will be applied topically, then rinsed with saline prior to in vivo confocal imaging with the hand-held probe. Following that, a biopsy of the suspicious site will be performed irrespective of the confocal microscopy finding. A biopsy of the normal site will be taken for research purposes. The confocal probe imaging will not alter where and how the biopsies will be taken (no change to size of biopsy or location on cervix). The procedure will add approximately 15 minutes to the duration of the standard outpatient procedure. During each examination, the anatomical location of all tissue areas in question will be recorded using the clock-position nomenclature system. Some normal areas will be also localized and recorded as control. Digital images will be recorded in the computer.

Interventions

DEVICEIn Vivo Confocal Microscopy Probe

Participants will have 2 areas on their cervical imaged by the confocal probe.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
British Columbia Cancer Agency
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* indicate understanding of the study * provide informed consent to participate * 18 years old or older * not pregnant and have negative urine pregnancy test * be schedule for colposcopy & biopsy at the Vancouver General Hospital Women's Clinic

Exclusion criteria

* they are breast-feeding * they had an operation to remove their cervix

Design outcomes

Primary

MeasureTime frame
Detection of pre-cancer abnormalities of the cervix by the confocal microscopy probeProbe measurements on participant's cervix should take no more than 10 minutes during the clinical visit

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026